U.S Physical Therapy - 15 Year Stock Price History | USPH
Historical daily share price chart and data for U.S Physical Therapy since 2011 adjusted for splits and dividends. The latest closing stock price for U.S Physical Therapy as of September 16, 2026 is 83.39.
- The all-time high U.S Physical Therapy stock closing price was 130.91 on November 06, 2019.
- The U.S Physical Therapy 52-week high stock price is 93.50, which is 12.1% above the current share price.
- The U.S Physical Therapy 52-week low stock price is 58.19, which is 30.2% below the current share price.
- The average U.S Physical Therapy stock price for the last 52 weeks is 77.19.
| U.S Physical Therapy Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 74.7124 | 77.3811 | 86.4652 | 58.2228 | 83.3900 | 8.86% |
| 2025 | 77.2230 | 84.2085 | 90.8160 | 62.7279 | 76.6061 | -9.88% |
| 2024 | 89.7283 | 87.9139 | 106.6080 | 73.8808 | 85.0038 | -2.97% |
| 2023 | 92.8577 | 75.4777 | 114.7220 | 73.8696 | 87.6035 | 16.98% |
| 2022 | 87.2714 | 91.0362 | 119.1680 | 68.5557 | 74.8862 | -13.67% |
| 2021 | 102.0389 | 106.4090 | 126.8630 | 76.7471 | 86.7422 | -19.49% |
| 2020 | 81.7234 | 100.7220 | 119.4540 | 42.9237 | 107.7350 | 5.52% |
| 2019 | 106.1193 | 90.4316 | 130.9070 | 87.9203 | 102.0970 | 12.81% |
| 2018 | 86.9282 | 64.3447 | 113.4010 | 63.2935 | 90.5023 | 43.09% |
| 2017 | 57.3759 | 61.3000 | 67.4430 | 49.6554 | 63.2497 | 4.14% |
| 2016 | 49.4923 | 44.5424 | 61.9056 | 39.8818 | 60.7376 | 32.35% |
| 2015 | 40.8470 | 34.2244 | 47.7969 | 32.4592 | 45.8932 | 29.49% |
| 2014 | 29.4315 | 28.2523 | 36.4367 | 25.1464 | 35.4407 | 20.68% |
| 2013 | 23.5906 | 22.9296 | 29.4434 | 18.7852 | 29.3684 | 29.94% |
| 2012 | 19.5490 | 16.1897 | 22.6013 | 14.9713 | 22.6013 | 44.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.220B | $0.781B |
| U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |